← Back to Clinical Trials
Recruiting NCT07365761

NCT07365761 Emotional Assessment and Tiered Individualized Psychological Support of the Artificial Intelligence Robot

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07365761
Status Recruiting
Phase
Sponsor National Taiwan University Hospital
Condition Emotional Assessment
Study Type INTERVENTIONAL
Enrollment 130 participants
Start Date 2025-10-01
Primary Completion 2026-07-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
E-MOTE group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 130 participants in total. It began in 2025-10-01 with a primary completion date of 2026-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To develop the E-MOTE robot and evaluate its effectiveness in addressing psychological distress, physical symptom, stress index, and quality of life, as well as to explore its clinical applicability.

Eligibility Criteria

Stage 1 (For patients and nurse) \*\*\*Patients\*\*\* Inclusion Criteria: * Aged 18 years or older. * Diagnosed with gynecologic cancer and undergoing surgery. * Willing to receive E-MOTE robot and wear a smart wearable device. * Willing to complete pre-test and post-test questionnaires. Exclusion Criteria: * Unable to communicate clearly. * Unwilling or unable to participate in the study in its entirety. \*\*\*Nurse\*\*\* Inclusion Criteria: * Aged 18 years or older. * As a clinical nurse and has cared for patients who received the E-MOTE robot Exclusion Criteria: \- Unwilling to participate in the qualitative interview. Stage 2 (only for patients) \*\*\*Intervention group\*\*\* Inclusion Criteria: * Aged 18 years or older. * Diagnosed with gynecologic cancer and scheduled to undergo surgery. * Willing to receiveE-MOTE robot and to wear a smart wearable device. * Willing to complete pre-test and post-test questionnaires. Exclusion Criteria: * Unable to communicate clearly. * Unwilling or unable to participate in the study in its entirety. \*\*\*Control group\*\*\* Inclusion Criteria: * Aged 18 years or older. * Diagnosed with gynecologic cancer and scheduled to undergo surgery. * Willing to complete pre-test and post-test questionnaires. Exclusion Criteria: * Unable to communicate clearly. * Unwilling or unable to participate in the study in its entirety.

Contact & Investigator

Central Contact

Yun-Hsiang Lee Associate Professor, PhD

✉ yhlee338@ntu.edu.tw

📞 +886 978082338

Frequently Asked Questions

Who can join the NCT07365761 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Emotional Assessment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07365761 currently recruiting?

Yes, NCT07365761 is actively recruiting participants. Contact the research team at yhlee338@ntu.edu.tw for enrollment information.

Where is the NCT07365761 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT07365761 clinical trial?

NCT07365761 is sponsored by National Taiwan University Hospital. The trial plans to enroll 130 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology